Triumvira Immunologics, Inc. is a pioneering biotechnology research company dedicated to discovering cures and providing renewed hope for patients facing life-threatening diseases. Operating from its primary location at 9433 Bee Cave Rd, Austin, Texas 78733, US, and with a presence at 175 Longwood Rd S, Hamilton, Ontario L8P, CA, Triumvira Immunologics is committed to innovation and excellence in the field of immunotherapy.
Triumvira Immunologics is focused on advancing its proprietary T cell Antigen Coupler (TAC) technology, which is believed to offer a safer and more effective alternative to existing cancer treatments like CAR and engineered T cell receptor (TCR) therapies. By bringing together top talent from diverse disciplines, Triumvira Immunologics is driving cutting-edge research and development in immunobiology, drug development, and commercialization.
With a passion for science and a deep commitment to patient well-being, Triumvira Immunologics is poised to make significant contributions to the field of oncology and beyond. The company continues to expand its partnerships and push the boundaries of what is possible in cell and gene therapy. We invite the manager of Triumvira Immunologics, Inc. to enhance your company's visibility by creating a customized and exclusive company showcase and product listing on our platform.
Compare Triumvira Immunologics, Inc. with 3 companies in Biotechnology-Research
| Comparison Field |
Triumvira Immunologics, I...Main Company |
Novartis in SloveniaView Profile |
Sayre TherapeuticsView Profile |
Snow Leopard Consult...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 0 | 2015 | 2020 |
|
Company Size
|
— | 1,001-5,000 | 11-50 | 1 employee |
|
City
|
Austin, Texas | Ljubljana, Ljubljana | Bangalore, KARNATAKA | Greater Boston, Massachusetts |
|
Country
|
United States | Slovenia | India | |
|
Skills & Keywords
Comparing with main company
|
10 Total Skills
Biotechnology
Immunology
Oncology
Cell Therapy
Gene Therapy
T cell Antigen Coupler
Clinical Development
Clinical Developement
Partnerships
Cell & Gene Therapy
|
13 Total
13 Unique
Unique Skills:
Cardiovascular
Data & Digital
Dhermatology
Disease
Infectious
Innovation
+7
|
10 Total
10 Unique
Unique Skills:
@SayreTx (on Twitter)
Branded Generics
CDx
Interventional Oncology
Molecular Diagnostics
neuro-Oncology
+4
|
24 Total
1 Common
23 Unique
Match
10%
Common Skills:
Gene Therapy
Unique Skills:
Biologics
BLA
Briefing Booklets
Developmental & Reproductive Toxicology
Genetic Toxicity
Health Authority Representation
+17
|
Other organizations in the same industry
This company is also known as